Papillary renal cell carcinoma has reduced cancer-specific mortality post-surgery
A study conducted by researchers at the Mannheim Medical Centre [...]
A study conducted by researchers at the Mannheim Medical Centre [...]
Despite significant improvements in the treatment outcomes of clear cell [...]
Patients diagnosed with a rare kidney cancer are often treated [...]
Chi-Med (Hutchinson Pharma), a Hong Kong-based biotechnology company, and AstraZeneca [...]
This video interview summarises treatments in development for papillary renal [...]
A recent paper published in European Urology has characterised the [...]
Nivolumab has demonstrated a substantial objective response rate and was [...]
In this video, Dr W. Marston Linehan, chief of the [...]
Papillary renal cell carcinoma (pRCC) is the second most common [...]
A new drug that targets a key enzyme that cancer [...]